---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282838018.md"
description: "Boyun New Materials: In 2025, the company's annual turnover was 910 million yuan, of which revenue from commercial aerospace products was approximately over 2 million yuan, accounting for a low proportion of main business revenue (less than 1%). In 2025, revenue from cemented carbide products accounted for 64.34% of total turnover"
datetime: "2026-04-15T11:47:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282838018.md)
  - [en](https://longbridge.com/en/news/282838018.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282838018.md)
---

# 

Boyun New Materials: In 2025, the company's annual turnover was 910 million yuan, of which revenue from commercial aerospace products was approximately over 2 million yuan, accounting for a low proportion of main business revenue (less than 1%). In 2025, revenue from cemented carbide products accounted for 64.34% of total turnover.

### Related Stocks

- [002297.CN](https://longbridge.com/en/quote/002297.CN.md)

## Related News & Research

- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)
- [Valhalla Metals Announces Closing of First Tranche of Over-Subscribed Private Placement | VMXXF Stock News](https://longbridge.com/en/news/286904505.md)
- [16:51 ETBeverly Hills MD ProRetinol Age Rewind x3 Officially Launches: A New Era of Gentle, Slow-Released Retinol Skincare Backed by Plastic Surgeons](https://longbridge.com/en/news/286966075.md)
- [China’s LandSpace Completes Heavy Payload Rocket Test, Paving Way for Multi-Satellite Missions](https://longbridge.com/en/news/286398536.md)
- [Vast Therapeutics Presents Late-Breaking Phase 1 Data for Inhaled Therapy ALX1 at ATS 2026](https://longbridge.com/en/news/286795160.md)